Last reviewed · How we verify
Belantamab mafodotin frozen liquid
Belantamab mafodotin frozen liquid is a Monoclonal antibody-drug conjugate Small molecule drug developed by GlaxoSmithKline. It is currently in Phase 2 development for Multiple myeloma.
Belantamab mafodotin is a monoclonal antibody-drug conjugate that targets BCMA.
Belantamab mafodotin is a monoclonal antibody-drug conjugate that targets BCMA. Used for Multiple myeloma.
At a glance
| Generic name | Belantamab mafodotin frozen liquid |
|---|---|
| Sponsor | GlaxoSmithKline |
| Drug class | Monoclonal antibody-drug conjugate |
| Target | BCMA |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
It binds to BCMA on the surface of multiple myeloma cells, delivering a cytotoxic agent that kills the cells. This approach is designed to minimize damage to healthy cells.
Approved indications
- Multiple myeloma
Common side effects
- Neutropenia
- Thrombocytopenia
- Anemia
- Fatigue
- Nausea
- Diarrhea
Key clinical trials
- A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody (PHASE2)
- Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Belantamab mafodotin frozen liquid CI brief — competitive landscape report
- Belantamab mafodotin frozen liquid updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Belantamab mafodotin frozen liquid
What is Belantamab mafodotin frozen liquid?
How does Belantamab mafodotin frozen liquid work?
What is Belantamab mafodotin frozen liquid used for?
Who makes Belantamab mafodotin frozen liquid?
What drug class is Belantamab mafodotin frozen liquid in?
What development phase is Belantamab mafodotin frozen liquid in?
What are the side effects of Belantamab mafodotin frozen liquid?
What does Belantamab mafodotin frozen liquid target?
Related
- Drug class: All Monoclonal antibody-drug conjugate drugs
- Target: All drugs targeting BCMA
- Manufacturer: GlaxoSmithKline — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Multiple myeloma
- Compare: Belantamab mafodotin frozen liquid vs similar drugs
- Pricing: Belantamab mafodotin frozen liquid cost, discount & access